Tispa Medical

Supercritical CO2

The increasing demand for sustainable and environmentally viable technology in the process industry, has caused an increase in the interest in supercritical solvent applications.

The critical point of a substance was discovered in 1822 by the French Baron Cagniard de la Tour. Heating a liquid over a fire in a sealed gun barrel, he concluded from the sound of a moving rock inside the barrel, that at some point the differences between liquid and gas phase fade and even disappear. The temperature and pressure at which this occurred was called the Cagniard de la Tour Point. Later this was defined as the critical point.

Supercritical fluids are hybrid solvents, with features between those of a liquid and a gas. They have a low viscosity, high diffusivity and a very low surface tension. Above that, these features are dependent of pressure and temperature, which makes them ‘tuneable’.

Supercritical CO2 is the most common fluid used, because supercritical state is reached at relatively low temperature and pressure. CO2 is also cheap, non-toxic and generally harmless and abundantly available.

Supercritical CO2

News

  • HET Instrument 2010

    Bezoek Tispa Medical op HET INSTRUMENT
    van 28 sept. t/m 1 okt 2010
    RAI Amsterdam
    di - do van 11.00 - 19.30
    vrij 10.30 - 16.00

    Standnummer 1A 165

    Lees verder voor gratis toegang en openbaar vervoer

  • US Patent awarded

    Tispa Medical is proud to announce that the solvent free and fast histological processing method is now patented in the United States. This opens promising opportunities for expansion of the company.

  • Tispa in Regionaleuropäischer Wirtschafts-Spiegel

    The Tispa Medical process is featured in the October/November 2009 issue of the German magazine Regionaleuropäischer Wirtschafts-Spiegel. Read more and find the link

  • Job Opportunities

    Tispa Medical offers Job opportunities to build a valuable and rewarding career